MedPath
HSA Approval

GERSKIN TABLET

SIN07893P

GERSKIN TABLET

GERSKIN TABLET

October 31, 1994

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A02AF02

ordinary salt combinations and antiflatulents

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y S P INDUSTRIES (M) SDN BHD

Active Ingredients

DIMETHYLPOLYSILOXANE

20 mg

Dimethicone

MAGNESIUM OXIDE

200 mg

Magnesium oxide

ALUMINIUM HYDROXIDE GEL DRIED

200 mg

Aluminium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GERSKIN TABLET - HSA Approval | MedPath